The CMT Research Foundation (CMTRF), the only nonprofit organization focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease* (CMT), is pleased to announce support from Alan Jackson’s LAST CALL ONE MORE FOR THE ROAD TOUR 2024-2025 dates. Building on the success of Jackson’s 2022 tour, the Tour will continue to support and raise awareness for CMT by donating one dollar from every ticket sold and will be bolstered by the commitment of a generous group of CMTRF donors who will match Jackson’s donation, doubling the financial impact.
“The continued support of Alan Jackson’s Tour amplifies our reach and intensifies our efforts in the battle against CMT. This unique partnership merges Alan’s musical legacy with our commitment to advancing CMT research,” said CMTRF CEO Cleary Simpson. “The generous matching of funds by our donors not only doubles the impact but also reinforces the solidarity and commitment of our community towards this cause.”
Alan Jackson, a venerated icon in country music (inducted into the Country Music Hall of Fame in 2017) who revealed his own CMT diagnosis in 2021, continues to leverage his influence and platform to champion the cause of CMT research. His decision to disclose his CMT diagnosis on NBC’s Today show has been pivotal in increasing public awareness and funding for research.
The new tour dates will feature stops in the announced cities below, providing fans with the opportunity to experience the breadth of Jackson’s nearly four-decade career in music while contributing to a critical cause.
In her remarks, Simpson highlighted the importance of community involvement: “Each ticket sold is a lighthouse of hope for thousands affected by CMT. Through Alan’s tour, we not only raise funds but also elevate understanding of this disease, which is crucial for our ongoing research and outreach efforts.”
Since its inception, CMTRF has made remarkable strides in funding pioneering research aimed at understanding and curing CMT. With over $17 million raised and numerous projects funded, the Foundation’s efforts have significantly advanced the scientific community’s approach to treating this disease. The projects funded by CMTRF are carefully selected based on their potential to achieve clinical and commercial success, ensuring that every dollar raised is invested effectively.
As the tour dates approach, CMTRF urges supporters to join them in this vital effort. Tickets and a full listing of concert dates are available at alanjackson.com/tour. Each purchase not only promises an evening of unforgettable music but also contributes to a noble cause, with the dollar match by CMTRF’s committed donors.
ALAN JACKSON’S 2024 – 2025 LAST CALL: ONE MORE FOR THE ROAD TOUR
2024
Friday, August 2 • Boston, MA (TD Garden)
Saturday, August 24 • Grand Rapids, MI (Van Andel Arena)
Saturday, September 28 • Fayetteville, AR (Bud Walton Arena)
Saturday, October 26 • Kansas City, MO (T-Mobile Center)
Saturday, November 16 • Salt Lake City, UT (Delta Center)
2025
Saturday, January 18 • Oklahoma City, OK (Paycom Center)
Saturday, February 15 • Fort Worth, TX (Dickies Arena)
Friday, March 7 • Orlando, FL (Kia Center)
Saturday, April 26 • Tampa, FL (Amalie Arena)
Saturday, May 17 • Milwaukee, WI (Fiserv Forum)
CMT Research Foundation (CMTRF) is a patient-led, non-profit focused on delivering treatments and cures for CMT. The foundation identifies significant obstacles or deficiencies impeding progress toward a cure and seeks out collaborators to address these issues. To date, CMTRF has funded 24 projects, of which 6 are completed. Of those 6 completed projects, 5 have clinical candidates. CMTRF’s mission to invest in promising science with high potential of leading to treatments and cures was proven effective and ground-breaking when DTx Pharma with a CMTRF- backed program as its lead candidate was acquired by Novartis for $1 billion. Founded by two patients who are driven to expedite drug delivery to people who live with CMT, the 501(c)(3) federal tax-exempt organization is supported by personal and corporate financial gifts.
*Charcot-Marie-Tooth encompasses a group of inherited, chronic peripheral neuropathies that result in deterioration of peripheral nerves that control sensory information and muscle function of the foot/lower leg and hand/forearm leading to significant problems with movement, touch, and balance as it advances. CMT can vary greatly in severity, even within the same family. CMT can cause severe disability and in rare instances, even death. At the moment, there is no treatment or cure for CMT.
Alan Jackson — A member of the Country Music Hall of Fame and an inductee to the Songwriters Hall of Fame, Alan Jackson’s membership among music’s all-time greats is part of a long line of career-defining accolades that include three CMA Entertainer of the Year honors, over 30 years of membership in the Grand Ole Opry, a Billboard ranking as one of the Top 10 Country Artists of All-Time, induction to the Nashville Songwriters Hall of Fame, and the Heritage Award as the most-performed country songwriter-artist of ASCAP’s first 100 years.
The man from rural Newnan, GA has sold nearly 60-million albums worldwide, ranks as one of the 10 best-selling male vocalists of all-time (rock, pop and country). He has released more than 60 singles – registering 50 Top Ten hits and 35 #1s (including 26 Billboard chart-toppers). He has earned more than 150 major music industry awards – including 19 Academy of Country Music Awards, 17 Country Music Association Awards (including the Willie Nelson Lifetime Achievement Award), a pair of Grammys and ASCAP’s Founders and Golden Note Awards. Jackson – one of the most successful and respected singer-songwriters in music – is also the man behind one of Nashville’s most-popular tourist stops, AJ’s Good Time Bar. The four-story honky-tonk in the heart of downtown featuring daily live music and a rooftop view of Music City set the bar – literally – for the many celebrity establishments in the city as the first – and still the only solely-owned – artist bar on Broadway.
